Alpha interferon as first line therapy for angioimmunoblastic lymphoadenopathy. Possible value of DR+ cells in monitoring therapeutical response

Haematologica. 1992 Nov-Dec;77(6):524-5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers
  • HLA-DR Antigens / analysis*
  • Humans
  • Immunoblastic Lymphadenopathy / therapy*
  • Immunologic Factors / therapeutic use*
  • Immunophenotyping
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Lymphocyte Subsets / immunology*
  • Male
  • Recombinant Proteins
  • Remission Induction

Substances

  • Biomarkers
  • HLA-DR Antigens
  • Immunologic Factors
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins